Trimetazidine

CAS : 5011-34-7

Ref. 3D-FAA01134

Informations sur le produit

• Nom: Trimetazidine
• Synonymes: 1-(2,3,4-Trimethoxybenzyl)Piperazine, 1-[(2,3,4-Trimethoxyphenyl)methyl]piperazine, 4-(2,3,4-Trimethoxybenzyl)piperazine, Piperazine, 1-(2,3,4-trimethoxybenzyl)-, Piperazine, 1-[(2,3,4-trimethoxyphenyl)methyl]-, Preductal, Preductal MB, Trimetazidine ( base and/or unspecified salts), Trimetazidine (TMZ), Vasorel

Description

Trimetazidine is a potent anti-ischemic and anti-anginal agent that has been shown to inhibit apoptosis in human cell lines. It acts as a kinase inhibitor, modulating the activity of various enzymes involved in cell cycle regulation and protein synthesis. Trimetazidine has been found to be an effective analog for the treatment of tumors, acting as an inhibitor of tumor cell growth and inducing apoptosis in cancer cells. Additionally, it has been shown to reduce the risk of urinary tract infections in patients undergoing chemotherapy. Overall, Trimetazidine is a promising anticancer agent with potential therapeutic applications.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 266.34 g/mol
• Formule: C₁₄H₂₂N₂O₃
• Degré de pureté: Min. 95%